Intercellular Communication Peptides in Canada: A Research Guide to Inflammaging, Secretomes, Senescence Signals, GHK-Cu, Thymosin Alpha-1, NAD+, SS-31, and MOTS-c

Why intercellular communication needed its own anti-ageing peptide guide#

Northern Compound already covers cellular senescence, immunosenescence, inflammation resolution, stem-cell niche biology, nutrient sensing, mitochondrial peptides, and sirtuin signalling. Those pages all touch communication between cells because ageing biology is not cell-autonomous. What was missing was a communication-first article: how should Canadian readers evaluate peptide claims when the endpoint is cytokine tone, senescence-associated secretome, extracellular vesicles, matrix crosstalk, immune remodelling, or tissue-level signalling?

That gap matters because "cellular communication" sounds sophisticated but often becomes vague marketing. A supplier page may mention lower inflammation and imply better ageing. A paper may show an altered fibroblast secretome and be repeated as if it proves skin rejuvenation. A mitochondrial study may reduce stress signalling and be described as immune optimisation. A senescent-cell model may lower IL-6 and be framed as reversed ageing. Those are different claims.

The modern hallmarks-of-ageing framework includes altered intercellular communication as one of several connected hallmarks, beside genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem-cell exhaustion, chronic inflammation, microbiome disturbance, and other layers (PMID: 23746838; PMID: 36599349). That framing is useful because it prevents reductionism. A single cytokine change is not the hallmark. It is one signal inside a larger system.

This guide is written for Canadian readers evaluating research-use-only peptide materials, endpoint logic, supplier documentation, and cautious evidence claims. It does not provide medical advice, immune advice, dermatology advice, anti-ageing treatment guidance, route selection, dosing, compounding instructions, or recommendations for personal use. Clinical and cosmetic words appear only because they are common in the literature and in supplier claims that need careful interpretation.

The short answer: name the message, the sender, and the receiver#

A defensible intercellular-communication study starts with three questions: what message changed, which cell produced it, and which cell or tissue responded? "Improves cellular communication" is not a result. "Reduced fibroblast IL-6 and MMP-1 secretion after oxidative stress while preserving viability and collagen deposition" is closer. "Altered extracellular-vesicle cargo from senescent endothelial cells and changed macrophage inflammatory markers in co-culture" is stronger still.

Within the current live product map, GHK-Cu is the strongest reference when the communication question involves fibroblast secretome, matrix remodelling, wound-edge signalling, collagen organisation, copper-peptide biology, or skin-adjacent tissue repair models. Thymosin Alpha-1 is relevant when the hypothesis is immune communication: antigen presentation, T-cell-adjacent context, dendritic-cell signalling, antiviral-model cytokines, or immune ageing models. NAD+, SS-31, and MOTS-c belong when metabolic or mitochondrial state is hypothesised to reshape secreted signals. Epitalon can be a circadian or ageing-biology comparator when timing and clock-state are part of the communication model.

Those ProductLinks are documentation checkpoints for research-use-only materials. They are not evidence that any material treats inflammation, reverses ageing, improves immunity, repairs tissue, improves skin, or belongs in personal use.

Intercellular communication in ageing biology, without the hand-waving#

Cells communicate through soluble cytokines, chemokines, hormones, growth factors, lipid mediators, matrix fragments, metabolites, extracellular vesicles, direct cell-cell contact, neuronal signals, vascular cues, and mechanical forces. Ageing can disrupt those systems by changing which cells speak, what they secrete, how recipient cells respond, and whether tissue architecture allows the signal to remain local or become systemic.

Senescent cells are one obvious example. They can remain metabolically active while secreting inflammatory cytokines, chemokines, proteases, growth factors, and matrix-remodelling molecules. That senescence-associated secretory phenotype, or SASP, can recruit immune cells, reinforce arrest, alter neighbouring-cell behaviour, and affect tissue structure. But SASP is not one molecule. It changes by cell type, trigger, time, culture conditions, tissue, and species. Reviews of senescence biology emphasise this context dependence rather than a universal "bad cytokine" pattern (PMID: 25399483; PMC4166495).

Mitochondrial dysfunction is another communication layer. Stressed mitochondria can alter ROS, NAD+/NADH state, ATP, innate immune activation, mitophagy signals, and damage-associated molecular patterns. A peptide that improves mitochondrial readouts may indirectly change cytokine output because the cell is less stressed. That is scientifically interesting, but the correct claim is still layered: mitochondrial stress changed, and communication endpoints changed alongside it. It is not proof of systemic rejuvenation.

Matrix biology adds a third layer. Fibroblasts, endothelial cells, immune cells, keratinocytes, stem-cell niches, and sensory nerves all read the extracellular matrix. Collagen organisation, stiffness, elastin, hyaluronan, proteoglycans, MMPs, TIMPs, and wound-edge tension can change how cells signal to one another. A copper-peptide or repair-associated model may therefore show cytokine changes because matrix context improved, because fibroblast phenotype changed, because cell viability improved, or because the assay was less irritated. The study has to identify which layer carried the effect.

GHK-Cu: matrix signalling can be communication, but not by default#

GHK-Cu is the most natural live product reference for matrix-centred communication research. GHK-Cu literature is often discussed around fibroblast behaviour, collagen and elastin context, glycosaminoglycans, wound models, antioxidant signalling, and gene-expression patterns. Reviews summarise its broad tissue-remodelling associations while also showing why endpoint specificity matters (PMC6073405; PMID: 18644225).

In a communication-first study, the question is not simply whether GHK-Cu changed collagen. The stronger question is whether it changed the signals that cells use to coordinate remodelling. A dermal fibroblast model might measure collagen I/III, elastin, MMP-1, MMP-2, TIMP-1, TGF-beta, IL-6, IL-8, VEGF, hyaluronan, fibroblast proliferation, senescence markers, oxidative-stress markers, and keratinocyte migration in conditioned-media experiments. A wound-edge model might add macrophage phenotype, endothelial markers, histology, and mechanical context.

The common mistake is to turn matrix improvement into global anti-ageing language. Better collagen organisation in a cell or animal model does not prove rejuvenation. Lower IL-8 in stressed fibroblasts does not prove immune balancing. Faster closure in a scratch assay does not prove human wound healing. Those endpoints can support a communication hypothesis only when the sender cell, recipient cell, matrix state, and functional outcome are measured together.

Copper context matters. A study should distinguish GHK-Cu from vague "copper peptide" language. It should control pH, chelators, serum proteins, oxidative state, copper salt contamination, vehicle effects, and colour-based identity assumptions. For Canadian RUO sourcing, lot-specific HPLC, identity confirmation, fill amount, batch number, storage guidance, and clear research-use-only labelling are part of the protocol, not a shopping preference.

Thymosin Alpha-1: immune communication needs cell-type discipline#

Thymosin Alpha-1 belongs in this article when the model is immune communication. It is usually discussed around T-cell-adjacent biology, dendritic-cell signalling, innate immune responses, and antiviral or immune-modulation research contexts. That makes it relevant to ageing because immunosenescence and inflammaging both involve altered immune messaging.

But immune communication is easy to overstate. A cytokine panel can change because antigen-presenting cells matured, because macrophage activation shifted, because T-cell subsets changed, because the stimulus changed, because the cells were stressed, or because the material contained an immune-active contaminant. A serious Thymosin Alpha-1 protocol should name the cell types and stimuli: dendritic cells, T cells, macrophages, epithelial cells, peripheral blood mononuclear cells, viral mimics, Toll-like receptor ligands, inflammatory cytokines, ageing-model tissue, or co-culture.

Useful endpoints may include IL-6, IL-10, TNF-alpha, interferon-stimulated genes, antigen-presentation markers, CD4/CD8 context, regulatory T-cell markers, macrophage markers, dendritic-cell maturation, NF-kB, JAK/STAT, cell viability, and time-course sampling. If the study claims immune ageing relevance, it should add age-context variables rather than borrowing conclusions from acute immune stimulation alone.

The sourcing bar is high because immune assays are sensitive. Endotoxin, microbial contamination, residual solvent, wrong identity, degradation products, and storage damage can all produce false immune signals. A current product page may help readers inspect batch documentation. It does not establish that the material improves immune function, treats infection, modulates disease, or belongs in personal use.

NAD+, SS-31, and MOTS-c: metabolic state can reshape messages#

NAD+, SS-31, and MOTS-c are not communication peptides in the same way that a cytokine is a communication molecule. They belong here because metabolic and mitochondrial state can change what cells secrete and how recipient cells respond.

NAD+ biology intersects with redox state, sirtuins, PARPs, DNA-damage response, CD38-associated metabolism, mitochondrial function, and inflammatory signalling. Northern Compound's sirtuin signalling guide covers that lane directly. In communication research, the key question is whether altered NAD+ context changed a signalling output. A protocol might measure NAD+/NADH, SIRT1/SIRT3 activity, acetylation markers, PARP activity, NF-kB-linked cytokines, SASP factors, and recipient-cell response after conditioned-media transfer.

SS-31 is better framed as a mitochondrial inner-membrane and oxidative-stress comparator. If it improves respiration or reduces mitochondrial ROS, cytokine output may change because stress signalling changed. A useful communication panel would include oxygen consumption, membrane potential, lipid peroxidation context, ROS, ATP, inflammatory cytokines, mitochondrial DAMP markers where relevant, and recipient-cell readouts. Without mitochondrial data, the mechanism is missing. Without communication data, it remains a mitochondrial study.

MOTS-c sits near mitochondrial-derived signalling, AMPK, metabolic stress adaptation, and mitonuclear communication. That makes it interesting for intercellular communication, but also prone to hype. If a MOTS-c model changes glucose handling, AMPK, or inflammatory markers, the study should separate cell-autonomous metabolism from secreted communication. Conditioned-media experiments, co-culture, tissue-specific markers, and pathway inhibition can help show whether a message actually travelled between cells.

Epitalon and circadian timing: when the clock is the communication variable#

Epitalon is included as an ageing-biology comparator because circadian timing influences immune signals, endocrine signals, feeding behaviour, mitochondrial function, senescence markers, and tissue repair. If a protocol studies intercellular communication across time-of-day, light-cycle, sleep-wake, or clock-gene variables, Epitalon-adjacent literature may be relevant as context.

The warning is simple: clock context is not a shortcut to communication claims. A study that measures telomerase-adjacent or pineal-associated endpoints without cytokines, secretome, extracellular vesicles, or recipient-cell response should not become an intercellular-communication claim. Conversely, a study that measures cytokines but ignores sampling time may confuse circadian variation with peptide effect.

A stronger design would include time-of-day sampling, clock-gene markers where relevant, feeding and activity controls, inflammatory markers, tissue-specific endpoints, and material-quality documentation. The conclusion should say what changed and when, not that a peptide "restored youthful signalling."

What to measure before making a communication claim#

Source-cell identity#

Every communication claim needs a sender. Fibroblasts, keratinocytes, macrophages, endothelial cells, senescent cells, T cells, neuronal cells, adipocytes, muscle cells, and stem-cell niche cells do not produce the same messages. Bulk tissue results can be useful, but cell-specific markers or spatial methods make the interpretation stronger.

Recipient-cell response#

A secreted signal matters because another cell or tissue responds. Conditioned-media transfer, co-culture, receptor markers, downstream phosphorylation, transcriptional response, migration, differentiation, phagocytosis, matrix deposition, or immune-cell activation can all support recipient-cell interpretation. Measuring only the secreted molecule is a thinner claim.

Time course#

Communication unfolds over minutes, hours, days, or weeks. Acute NF-kB activation, delayed cytokine release, matrix remodelling, senescence reinforcement, extracellular-vesicle cargo changes, and tissue repair are not the same time scale. A one-time measurement can miss the real signal or capture a transient stress response.

Viability and cytotoxicity#

Lower cytokines can look favourable when cells are injured, depleted, senescent in a different way, or unable to signal. Viability, morphology, ATP, LDH release, cell count, apoptosis markers, and proliferation state should be measured. A dead or exhausted sender cell is not evidence of healthier communication.

Matrix and mechanical context#

Cells communicate through the matrix as well as soluble factors. Stiffness, collagen organisation, elastin, hyaluronan, MMPs, TIMPs, integrins, and tissue tension can change signalling. If a peptide is studied in repair, dermal, vascular, or stem-cell niche models, matrix endpoints should sit beside cytokine endpoints.

Extracellular-vesicle specificity#

Extracellular vesicles are fashionable and easy to mishandle. A study should document isolation method, particle size, concentration, protein markers such as CD63/CD81/TSG101 where appropriate, negative markers, cargo analysis, donor-cell state, uptake by recipient cells, and contamination controls. Conditioned media is not automatically an EV result.

Model selection: what each system can actually prove#

A communication article is only as strong as its model. Isolated cell culture can answer narrow sender-cell questions. Fibroblasts, keratinocytes, macrophages, endothelial cells, T cells, neuronal cells, adipocytes, or myotubes can be stimulated under controlled conditions and sampled for secreted factors. That is useful, but it cannot prove tissue-level ageing, immune coordination, wound quality, or systemic inflammation. It shows what one cell population did under one exposure and one context.

Conditioned-media experiments add a recipient-cell layer. A sender population is exposed, media is collected, and a second cell type is tested for migration, cytokine response, differentiation, matrix deposition, or stress markers. This can support communication better than a sender-only cytokine panel, but it needs strict controls: media composition, serum carryover, peptide carryover, pH, osmolarity, time in culture, filtration, and recipient-cell baseline state. If the peptide itself remains in the conditioned media, the recipient-cell effect may be direct exposure rather than sender-derived communication.

Co-culture models are stronger when the research question depends on reciprocal signalling. Keratinocyte-fibroblast, macrophage-fibroblast, endothelial-immune, neuronal-glial, adipocyte-macrophage, or senescent-cell-neighbour models can capture bidirectional crosstalk. They also add complexity. Cell ratios, contact versus transwell conditions, media compromises, donor variability, and endpoint attribution all matter. A co-culture result should avoid pretending that one cell type carried the whole effect unless the protocol separated the compartments or used cell-specific markers.

Organoids, spheroids, skin equivalents, vascularised tissue models, and ex vivo tissue can add architecture. These models are valuable because communication depends on distance, matrix, oxygen gradients, nutrient gradients, cell polarity, and tissue stiffness. They also introduce penetration and recovery questions. A peptide may not reach the intended cell layer evenly. Secreted factors may bind matrix. Hypoxia or necrotic centres can create false inflammatory signals. Strong protocols document model maturity, size, viability gradients, matrix formulation, exposure route, and peptide recovery.

Animal models can capture systemic communication: immune recruitment, endocrine context, vascular signalling, nervous-system inputs, tissue repair, and age-related organ interactions. They are also harder to interpret. Species differences, stress, housing, microbiome, diet, sex, age, activity, handling, and route can dominate communication endpoints. A cytokine shift in an animal model should be read as model-specific unless tissue, cell-type, and functional endpoints align. It should not be turned into a human anti-ageing or immune claim.

Human clinical, dermatology, immunology, or geroscience literature can provide context, but it sits outside RUO purchasing guidance. If a clinical study discusses inflammatory ageing or tissue repair, Northern Compound can use it to understand biology. It cannot be used to imply that a research-use-only supplier material is a treatment, cosmetic product, supplement, injectable protocol, or personal-use product.

Product mapping: match the compound to the communication layer#

The safest way to discuss products in this topic is to map each compound to a narrow research layer instead of a broad promise.

This mapping deliberately avoids dead or uncertain product links. Compounds can be mentioned in the broader literature without being turned into live sourcing links. If a slug is not confirmed live, Northern Compound should not present it as a ProductLink target. That protects readers from 404s and protects the editorial frame from implying availability where current store evidence is weak.

Endpoint panels by research claim#

If the claim is inflammaging#

Inflammaging claims should include more than one inflammatory marker. IL-6 and TNF-alpha are common, but a stronger panel includes IL-1 beta, IL-8, CCL2, CXCL10, CRP-like context where appropriate, NF-kB activation, JAK/STAT signalling, immune-cell composition, tissue source, and viability. In ageing models, baseline age, sex, tissue, diet, microbiome, stress, and sampling time can change the result. A peptide-associated decrease in IL-6 is a starting observation, not an anti-ageing conclusion.

If the claim is SASP modulation#

SASP modulation requires senescence confirmation. A useful study measures p16, p21, cell-cycle arrest, SA-beta-gal where appropriate, DNA-damage markers, morphology, proliferation status, and a panel of secreted factors such as IL-6, IL-8, MMPs, PAI-1, GM-CSF, and growth factors. It should also clarify whether the peptide reduced senescent-cell burden, altered SASP intensity, changed cell viability, or changed recipient-cell response. Those are separate outcomes.

If the claim is matrix communication#

Matrix communication needs both structure and signal. Collagen I/III, elastin, fibronectin, hyaluronan, MMP/TIMP balance, LOX context, stiffness, fibroblast phenotype, keratinocyte migration, macrophage response, and endothelial markers may all be relevant. GHK-Cu can be coherent here, but the endpoint panel should still distinguish matrix deposition, matrix organisation, secreted signalling, and functional tissue behaviour.

If the claim is immune coordination#

Immune coordination requires cell identity. A protocol should state whether it is studying macrophages, dendritic cells, T cells, NK cells, epithelial immune signalling, mixed PBMCs, or tissue immune infiltrates. Markers should match the claim: antigen presentation, cytokine output, phagocytosis, activation state, exhaustion markers, regulatory markers, or migration. Thymosin Alpha-1 is relevant only when that immune layer is explicit.

If the claim is mitochondrial-to-immune communication#

Mitochondrial stress can shape cytokine output, but the bridge must be shown. A strong panel includes oxygen consumption, ATP-linked respiration, membrane potential, ROS, mitochondrial DNA release where relevant, mitophagy markers, inflammatory cytokines, NF-kB or interferon pathways, and recipient-cell response. SS-31 or MOTS-c may be useful references depending on whether the design is inner-membrane stress or mitochondrial-derived signalling.

Canadian RUO sourcing checklist for communication-sensitive studies#

Communication endpoints are contamination-sensitive. Endotoxin, microbial burden, residual solvents, salts, incorrect pH, degradation products, oxidation, adsorption, freeze-thaw damage, and wrong identity can all alter cytokines, matrix markers, mitochondrial stress, and cell viability.

For GHK-Cu, Thymosin Alpha-1, NAD+, SS-31, MOTS-c, or Epitalon, Canadian readers should inspect:

1. exact material identity, sequence or molecular identity, and salt or complex form where relevant;
2. lot-specific HPLC purity or appropriate identity documentation rather than a generic catalogue claim;
3. mass confirmation, batch number, fill amount, test date, and storage guidance;
4. endotoxin and microbial-contamination awareness when cytokine, immune-cell, or co-culture endpoints are central;
5. stability under the actual assay conditions, including light, heat, moisture, pH, serum, chelators, and freeze-thaw exposure;
6. vehicle compatibility, adsorption to plastic, and matrix recovery where secretome or cell-culture assays are used;
7. clear research-use-only labelling with no disease-treatment, immune-boosting, skin-rejuvenation, anti-ageing, dosing, route, or personal-use claims.

A ProductLink is a route to inspect current supplier documentation while preserving attribution. It is not a recommendation to use a compound and not proof that a lot will produce any biological result.

How communication claims go wrong#

The first error is treating inflammation as a single direction. Lower IL-6 may be useful in one stress model and harmful in another if it reflects impaired immune recruitment, cytotoxicity, or timing. Higher cytokines may indicate activation, irritation, host defence, repair signalling, contamination, or stress. The endpoint needs context.

The second error is confusing sender and receiver. A fibroblast may secrete fewer MMPs, but that does not prove keratinocytes migrated better, macrophages changed phenotype, or matrix matured. A macrophage marker may shift, but that does not prove tissue repair improved. Communication needs at least two sides of the conversation.

The third error is converting secretome changes into rejuvenation. Senescent cells can change SASP intensity while remaining senescent. Mitochondria can become less stressed without reversing age. Matrix markers can improve in culture without restoring tissue architecture. Rejuvenation is a high bar and should rarely be used in RUO editorial writing.

The fourth error is ignoring material quality. Immune and secretome assays are some of the easiest assays to contaminate. If a vial lacks current identity, purity, storage, and endotoxin context, the study may be measuring the contaminant as much as the peptide.

The fifth error is borrowing clinical language. Inflammation, immunity, skin repair, infection, chronic disease, wound healing, and anti-ageing are clinical or consumer-facing frames. Northern Compound can discuss mechanistic literature, but RUO product links should stay inside documentation and research-design boundaries.

A practical evidence workflow for Canadian readers#

Start by writing the claim in one sentence. If the sentence says "improves cellular communication," it is not ready. Rewrite it with the sender, message, receiver, model, and time point. For example: "A verified GHK-Cu lot changed oxidative-stress-induced fibroblast IL-8, MMP-1, and collagen I markers over 48 hours while preserving viability and improving keratinocyte migration in conditioned-media controls." That sentence is testable.

Next, separate the biological question from the sourcing question. The biological question asks whether the endpoint panel can prove communication. The sourcing question asks whether the material is identifiable, pure, stable, correctly filled, and labelled research-use-only. Both questions must be answered. A sophisticated co-culture model is weak if the vial is undocumented. A clean COA does not prove communication biology.

Then place the result in a hierarchy. A cytokine change is a signal. A recipient-cell response is stronger. A tissue-level functional endpoint is stronger again. A repeated, independently replicated model with batch-level documentation is stronger than all of those. Let the weakest layer limit the conclusion.

Finally, keep the compliance language intact. This topic attracts anti-ageing and immune-performance claims because the biology is broad. Broad biology does not justify broad promises. The right Northern Compound stance is model-first, COA-first, and research-use-only.

Reference audit: how to read evidence without importing hype#

A useful communication article should make readers better at auditing references, not just give them a list of mechanisms. Start with the study model. If the paper used a young immortalised cell line, do not read it as aged tissue. If it used senescence induced by irradiation, do not assume the same SASP as oncogene-induced senescence, replicative exhaustion, mitochondrial stress, or inflammatory stimulation. If it used one animal strain under one diet, do not convert that into universal ageing biology.

Next, check whether the communication claim was direct or inferred. Direct evidence usually shows a sender-cell change, a secreted factor or contact-dependent signal, and a recipient-cell response. Inferred evidence may show only that inflammatory markers changed in bulk tissue. Inferred evidence can still be useful, but it should be labelled as such. The difference protects the article from overclaiming.

Then check whether the study separated peptide effect from vehicle, stress, and contamination. Communication endpoints move easily. Serum, antibiotics, plastics, pH, osmolarity, freeze-thaw handling, and cell density can all change cytokine output. In immune models, endotoxin controls are especially important. In copper-peptide work, chelators, protein binding, and copper state can change the result. In mitochondrial models, assay timing and oxygen conditions can dominate interpretation.

Finally, look for function. A lower cytokine panel is stronger when it is paired with improved matrix organisation, restored recipient-cell behaviour, better mitochondrial function, clearer immune-cell phenotype, or a tissue-specific endpoint. Function does not erase compliance boundaries, but it makes the research claim more meaningful. Without function, the safest language is "altered signalling under defined conditions."

What this article adds to the Northern Compound archive#

This guide sits between several existing pages rather than replacing them. The cellular senescence guide focuses on cell-state and SASP interpretation. The immunosenescence guide focuses on ageing immune function. The inflammation-resolution guide focuses on pro-resolving versus suppressive inflammatory logic. The stem-cell niche guide focuses on local tissue environments. The nutrient-sensing guide focuses on AMPK, mTOR, NAD+, and metabolic control.

The missing layer was the traffic between those systems. Intercellular communication is the question that asks how senescent fibroblasts affect neighbouring cells, how mitochondrial stress becomes inflammatory tone, how immune cells interpret tissue damage, how matrix remodelling changes cell behaviour, and how clock or metabolic state shifts secreted messages. That makes it a useful search-intent page for Canadian readers who are not asking for one compound guide, but for a framework to judge broad anti-ageing claims.

It also creates a cleaner ProductLink path. Rather than forcing every anti-ageing query toward a single compound, this article routes readers to the correct documentation lane: GHK-Cu for matrix-secretome questions, Thymosin Alpha-1 for immune communication, NAD+ for redox/sirtuin context, SS-31 for mitochondrial stress, MOTS-c for metabolic signalling, and Epitalon for clock-adjacent ageing models. That is better for trust and better for conversion because the link follows the research question.

FAQ#

Bottom line#

Altered intercellular communication is a useful anti-ageing research frame only when the conversation is named precisely. Cytokines are not tissue function. A secretome is not rejuvenation. Matrix remodelling is not immune balancing. Mitochondrial stress reduction is not proof of systemic youth. Each claim has to identify the sender, the message, the receiver, the timing, the endpoint, and the material quality behind it.

For Canadian readers, the practical rule is model-first and COA-first. Use GHK-Cu, Thymosin Alpha-1, NAD+, SS-31, MOTS-c, and Epitalon as documentation checkpoints and hypothesis anchors, not as clinical recommendations. If the claim cannot say who is signalling to whom, it is not ready to be trusted.